Navigation Links
Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer
Date:12/15/2009

KNOXVILLE, Tenn., Dec. 15 /PRNewswire/ -- Medical researchers with EDP Biotech Corporation (EDP) have captured national attention with their revolutionary new technology for a simple blood test to detect early-stage colon cancer.

Following the success of its pre-clinical trials for the ColoMarker(TM) assay, EDP has filed a patent on the biomarker, CA11-19, and all aspects of its use. Via an inexpensive blood test, ColoMarker(TM) will detect colon cancer in its earliest, most curable stages.

"American Cancer Society statistics show that when colon cancer is detected in its early stages, more than 90% of patients will survive. If not detected until the later stages, fewer than 10% will survive. ColoMarker(TM) detects colon cancer in these early, highly curable stages," says Kevin Jones, Ph.D., Chief Scientific Officer of EDP.

According to American Cancer Society statistics, fewer than 20% of Americans over the age of 50 who should be screened for colon cancer, actually are. With the use of ColoMarker(TM), a simple and inexpensive blood test, the number of people being screened would likely increase dramatically, leading to a decline in deaths due to colon cancer.

In pre-clinical trials, ColoMarker(TM) successfully detected the early stages (I, II, and III) of colon cancer. In tests of 2,370 blood samples, ColoMarker(TM) showed an accuracy rate of >99% for detecting colon cancer in these early stages. "ColoMarker(TM) could lead to a radical shift in the way we detect colon cancer," adds Dr. Jones.

National researchers who study colorectal cancer are closely monitoring emerging technologies such as ColoMarker(TM). Their findings are encouraging; just last week, the American Cancer Society, the National Cancer Institute, the Centers for Disease Control and Prevention and the North American Association of Central Cancer Registries released an optimistic report about the expected decline in deaths from colon cancer due to anticipated improvements in early screening methods.

Dr. Jones states, "The use of ColoMarker(TM) as a screening test could save tens of thousands of American lives every year and billions of dollars in healthcare costs." EDP Biotech is now moving forward expeditiously to get ColoMarker(TM) through the Food and Drug Administration clearance process.

For more information on ColoMarker(TM) or EDP Biotech Corporation, contact Jeff Hooper, Ackermann PR, and (865) 584-0550.

About EDP Biotech Corporation

EDP Biotech Corporation (EDP) is a medical device company focused on the development and sale of immunodiagnostic tests for both humans and animals. EDP utilizes more than 30 years of research and development in identification and purification of proteins present in the early stages of biological changes for production of in vitro diagnostic tests whose primary target is Early Detection Products.


    Jeff Hooper
    Ackermann PR
    (865) 584-0550
    jhooper@ackermannpr.com

SOURCE EDP Biotech Corporation


'/>"/>
SOURCE EDP Biotech Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. AVAC Says MDP 301 Microbicide Trial Results Disappointing, but Researchers and 9,400 Trial Volunteers Deserve Praise for Successful Trial
2. Neuro Kinetics & Military Researchers in Push To Improve Diagnosis & Treatment of Combat Brain Injuries
3. Sigma-Aldrich Announces SAGE(TM) Priority Partners Program; Seeks Researchers to Evaluate New Knockout Rat Models
4. New Effort to Battle Antibiotic Resistance Rallies Researchers Throughout Harvard University
5. Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis
6. Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive
7. Researchers Find High-Dose Therapy for Liver Disease Not Effective
8. Nucleix Researchers Discover DNA Evidence May Easily Be Falsified
9. Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
10. Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
11. Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M. Finzi Memorial Student Summer Fellowships to Five Students
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... 21, 2017 Taiwan Biophotonic Co. (tBPC), a ... vital signs sensing solutions, today announced the CE Marking ... pulse oximeter, the oCare TM Pro 100, which is ... medical devices space.  tBPC,s Wrist Pulse Oximeter, ... simple and reliable method to measure and record heart ...
(Date:2/20/2017)... , Feb. 20, 2017 Provides understanding ... agreements entered into by the worlds leading healthcare ... Description The Global Anemia Partnering Terms ... access to partnering deals and agreements entered into ... - Trends in partnering deals - Top ...
(Date:2/20/2017)... , Feb. 20, 2017  This Report analyzes the worldwide ... Dosage Forms: Injectables, Solid Dosage Forms, and Liquid & Semi-solid Dosage ... Canada , Japan , ... World. Read the full report: http://www.reportlinker.com/p04707109-summary/view-report.html ... Annual estimates ...
Breaking Medicine Technology:
(Date:2/19/2017)... Charleston, South Carolina (PRWEB) , ... February 19, 2017 , ... ... class of evening undergraduate nursing students, is being led by Amelia Joseph, Ph.D. Joseph ... direct the initial operations of the nursing department in early 2016. After a nation-wide ...
(Date:2/19/2017)... (PRWEB) , ... February 19, 2017 , ... ProBrand Glitch is a set of 30 ... ProBrand Glitch users can easily reveal any logo with a glitch reveal in just a ... control over the style and animation of each preset. Use these presets to add a ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... healthcare, will join forces with Healthwise ® at HIMSS 2017 ... industry leader in evidence-based health education, technology and services, will demonstrate a voice-powered ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, not ... the industry, according to the recent NEJM Catalyst Insights Report on the New ... NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, and ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos experiments ... Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that idea that ...
Breaking Medicine News(10 mins):